A systems biology view of cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1796, Issue 2, 2009, Pages 129-139

  Laubenbacher, Reinhard ^a,c   Hower, Valerie ^b   Jarrah, Abdul ^a   Torti, Suzy V ^c   Shulaev, Vladimir ^a,c   Mendes, Pedro ^a,c,d   Torti, Frank M ^c   Akman, Steven ^c  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cancer; Mathematical modeling; Systems biology

Indexed keywords

APOPTOSIS; B CELL LYMPHOMA; BREAST CANCER; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL METABOLISM; COLORECTAL CANCER; DNA DAMAGE; DNA MICROARRAY; DRUG RESEARCH; FEEDBACK SYSTEM; GENE MUTATION; GENETIC REGULATION; HUMAN; MATHEMATICAL MODEL; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RADIATION DOSE; REVIEW; SIGNAL TRANSDUCTION; SIMULATION; SOLID TUMOR; SYSTEMS BIOLOGY; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENES; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 70349182290     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.06.001     Document Type: Review

References (61)

1. Wood L.D., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 5853 (2007) 1108-1113
2. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 8 (2004) 789-799
3. Hornberg J.J., et al. Cancer: a systems biology disease. Biosystems 83 2-3 (2006) 81-90
4. Ahn A.C., et al. The limits of reductionism in medicine: could systems biology offer an alternative?. PLoS Medicine 3 6 (2006) e208
5. Ahn A.C., et al. The clinical applications of a systems approach. PLoS Medicine 3 7 (2006) e209
6. Stiles B., et al. Essential role of AKT-1/protein kinase B{alpha} in PTEN-controlled tumorigenesis. Mol. Cell. Biol. 22 11 (2002) 3842-3851
7. Rodriguez-Viciana P., et al. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15 10 (1996) 2442-2451
8. Tokunaga E., et al. Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. International Journal of Cancer 118 2 (2006) 284-289
9. Datta S.R., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 2 (1997) 231-241
10. Cardone M.H., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 5392 (1998) 1318-1321
11. Brunet A., et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96 6 (1999) 857-868
12. Mayo L.D., and Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proceedings of the National Academy of Sciences 98 20 (2001) 11598-11603
13. Inoki K., et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4 9 (2002) 648-657
14. Elstrom R.L., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64 11 (2004) 3892-3899
15. Kane L.P., et al. Induction of NF-[kappa]B by the Akt/PKB kinase. Curr. Biol. 9 11 (1999) 601-605
16. Lerebours F., et al. NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 8 (2008)
17. Futagami S., et al. COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells. Prostaglandins, Leukotrienes and Essential Fatty Acids 78 2 (2008) 137-146
18. Li Z., et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. PNAS 100 (2003) 8164-8169
19. Hatakeyama M., et al. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. Biochem. J. 373 2 (2003) 451-463
20. Stolovitzky G., Monroe D., and Califano A. Dialogue on reverse-engineering assessment and methods: the DREAM of high-throughput pathway inference. Ann. N. Y. Acad. Sci. 1115 (2007) 1-22
21. Hartemink A.J. Reverse engineering gene regulatory networks. Nat. Biotechnol. 23 5 (2005) 554-555
22. Laubenbacher R., and Stigler B. A computational algebra approach to the reverse engineering of gene regulatory networks. J. Theor. Biol. (2004)
23. Gardner T.S., et al. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301 5629 (2003) 102-105
24. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
25. Ribba B., Colin T., and Schnell S. A multiscale mathematical model of cancer, and its use in analyzing irratiation therapies. Theor. Biol. Med. Modelling 3 (2006) 7
26. Chuang H.Y., et al. Network-based classification of breast cancer metastasis. Mol. Sys. Biol. 3 (2007)
27. Mani K.M., et al. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol. Syst. Biol. 4 (2008)
28. Shachar R., et al. A systems-level approach to mapping the telomere length maintenance gene circuitry. Mol. Syst. Biol. 4 (2008) 172
29. Qi J.P., et al. A mathematical model of P53 gene regulatory networks under radiotherapy. Biosystems 90 3 (2007) 698-706
30. Birtwistle M.R., et al. Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol. Syst. Biol. (2007) EMBO and Nature Publishing Group
31. Athale C.A., and Deisboeck T.S. The effects of EGF-receptor density on multiscale tumor growth patterns. J. Theor. Biol. 238 4 (2006) 771-779
32. Huang P.H., et al. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc. Nat. Acad. Sci. 104 31 (2007) 12867-12872
33. Reymann S., and Borlak J. Transcription profiling of lung adenocarinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network. B.M.C. Sys. Biol. 2 (2008) 46
34. Kolch W. Ras/Raf signalling and emerging pharmacotherapeutic targets. Exp. Opin. Pharmacother. 3 (2002) 709-718
35. Kholodenko B.N., et al. Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor (1999) 30169-30181
36. Hendriks B.S., Wiley H.S., and Lauffenburger D. HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms. Biophys. J. 85 4 (2003) 2732-2745
37. Kumar N., et al. Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data. PLoS Computational Biology 3 1 (2007) e4
38. Castoria G., et al. Integrating signals between cAMP and MAPK pathways in breast cancer. Front. Biosci. 13 (2008) 1318-1327
39. Kiyatkin A., et al. Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops. J. Biol. Chem. 281 29 (2006) 19925-19938
40. Stites E.C., et al. Network analysis of oncogenic Ras activation in cancer. Science 318 5849 (2007) 463-467
41. Sveiczer A., Tyson J., and Novak B. Modelling the fission yeast cell cycle. Brief Funct. Genomic Proteomic 2 4 (2004) 298-307
42. Haberichter T., et al. A systems biology dynamical model of mammalian G1 cell cycle progression. Mol. Syst. Biol. 3 (2007) 84
43. Watt F., Frye M., and Benitah S. MYC in mammalian epidermis: how can an oncogene stimulate differentiation?. Nat. Rev., Cancer 8 3 (2008) 234-242
44. Bottani S., and Grammaticos B. Analysis of a minimal model for p53 oscillations. J. Theor. Biol. 249 2 (2007) 235-245
45. Geva-Zatorsky N., et al. Oscillations and variability in the p53 systems. Mol. Syst. Biol. 2006 2 (2006) 0033
46. Anderson A.R., et al. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127 (2006) 905-915
47. Jiang Y., et al. A multiscale model for avascular tumor growth. Biophys. J. 89 6 (2005) 3884-3894
48. Zhang L., Athale C.A., and Deisboeck T.S. Development of a three-dimensional agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes, and multicellular patterns in brain cancer. J. Theor. Biol. 244 (2007) 96-107
49. Anderson A.R., and Quaranta V. Integrative mathematical oncology. Nat. Rev., Cancer 8 (2008) 227-234
50. Mueller M.M., and Fusenig N.E. Friends or foes-bipolar effects of the tumor stroma in cancer. Nat. Rev., Cancer 4 (2004) 839-849
51. Weigelt B., Peterse J.L., and van't Veer L.J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5 8 (2005) 591-602
52. van de Vijver M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 25 (2002) 1999-2009
53. Wang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 9460 (2005) 671-679
54. Ramani A.K., et al. Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome. Genome Biol. 6 5 (2005) R40
55. Rual J.F., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437 7062 (2005) 1173-1178
56. van 't Veer L.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 6871 (2002) 530-536
57. Lefebvre C., et al. A context-specific network of protein-DNA and protein-protein interactions reveals new regulatory motifs in human B-cells. Lecture Notes in Bioinf 4532 (2007) 42-56
58. O'Brian K., Remm M., and Sonnhammer E. Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res. 33 Database issue (2005) D476-D480
59. Margolin A., et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. B.M.C. Bioinformatics 7 Suppl. 1 (2006) S1-S7
60. Djavani M., et al. Early blood profiles of virus infection in a monkey model for Lassa Fever. J. Virology 81 15 (2007) 7960-7973
61. Djavani M., et al. Gene expression in primate liver during viral hemorrhagic fever. J. Virology (2008) under review